FDA Approves New Drug for Hodgkin Lymphoma

News   Apr 20, 2017 | Original story from National Cancer Institute

 
FDA Approves Pembrolizumab for Hodgkin Lymphoma

Anatomical illustration of lymphoma. Credit: Terese Winslow

 
 
 
 

RELATED ARTICLES

Exosomes Offer Significant Potential in Detecting and Treating Disease

News

Exosomes - tiny biological nanoparticles which transfer information between cells - offer significant potential in detecting and treating disease, the most comprehensive overview so far of research in the field has concluded.

READ MORE

Lab Grown Human Colons Change Study of GI Disease

News

Researchers have grown human colon with human pluripotent stem cells, enabling further study of the GI tract and associated diseases.

READ MORE

Neurochoice Big Idea Initiative to Fight Opioid Epidemic in USA

News

Neurochoice brings together neuroscientists, psychologists, public policy scholars and others to tackle drug addiction and find better treatments and policies for dealing with the problem.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE